Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Neighbourly Pharmacy Inc T.NBLY.R


Primary Symbol: T.NBLY

Neighbourly Pharmacy Inc. is a Canada-based company that operates a network of community pharmacies. The Company is an owner and operator of retail pharmacies located throughout Canada under banners such as IDA/Guardian, Pharmachoice, Pharmasave and Remedy’s RX. The Company, through its subsidiaries, owns and operates a network of retail pharmacies known as Rubicon Pharmacies (Rubicon or Rubicon Pharmacies. The Company owns and operates approximately 287 locations across seven provinces and one territory, a coast-to-coast footprint that provides scale and diversification. The Company’s pharmacies provide accessible healthcare with a personal touch. The Company also owns British Columbia-based pharmacies.


TSX:NBLY - Post by User

Post by Kanatainvestoron Sep 05, 2023 2:03pm
105 Views
Post# 35620253

Canadian Consolidators YoY-23/24 EBITDA and EPS Growth (TD)

Canadian Consolidators YoY-23/24 EBITDA and EPS Growth (TD)                                                     EBITDA     EPS              
Boyd Group                               19%         35%
Constellation Software            22%        26%
FirstService                                10%        11%
GFL Envi.                                     8%        150%
MTY Food                                   -5%         20%
Neighbourly Pharmacy            44%       100%
Park Lawn                                  5%           9%
Premium Brands                     11%         32%
TFI International                       17%         27%
WELL Health                             25%        40%
WSP Global                              15%         19%
Dentlcorp                                   13%         17%

Average:                                   16%          44%

NBLY's EBITDA and EPS growth YoY (2023/2024) outlook is materially faster than average within the consolidators (roll-up) space and this is as of August 8th.


<< Previous
Bullboard Posts
Next >>